Table 3 Use of renin-angiotensin system inhibitors and incidence of fracture by age and gender
Variables | Fracture case | Controls | Conditional logistic regression | ||||
|---|---|---|---|---|---|---|---|
(n = 1,049) | (n = 1,049) | ||||||
n | % | n | % | OR (95% CI) | P-value | ||
Age (≤ 65 years) | Never-user | 295 | 51.7 | 276 | 48.3 | ||
Ever-user | 56 | 45.9 | 66 | 54.1 | 0.80 (0.42–1.51) | 0.486 | |
Age (66–70 years) | Never-user | 304 | 51.9 | 282 | 48.1 | ||
Ever-user | 87 | 48.1 | 94 | 51.9 | 0.51 (0.27–0.96) | 0.036 | |
Age (≥ 71 years) | Never-user | 220 | 50.0 | 220 | 50.0 | ||
Ever-user | 87 | 43.9 | 111 | 56.1 | 0.59 (0.31–1.12) | 0.109 | |
Male | Never-user | 545 | 51.6 | 512 | 48.4 | ||
Ever-user | 152 | 46.1 | 178 | 53.9 | 0.74 (0.55–1.00) | 0.050 | |
Female | Never-user | 274 | 50.7 | 266 | 49.3 | ||
Ever-user | 78 | 45.6 | 93 | 54.4 | 0.67 (0.41–1.10) | 0.114 | |